MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 14.11.2022
CASI Pharmaceuticals ROE 2011-2026 | CASI
ROE Jährlich CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -43.38 | -59.22 | -63.06 | -25.1 | -27.95 | -45.48 | 118.38 | 6205.99 | -38.4 | -176.62 | -180.05 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6205.99 | -180.05 | 515.01 |
ROE Vierteljährlich CASI Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.36 | -43.17 | -46.55 | -42.4 | -33.01 | -53.8 | -62.79 | -66.12 | -41.81 | -55.36 | -48.11 | -58.65 | -45.95 | -53.95 | -48.39 | -32.55 | -16.63 | -20.82 | -17.01 | -17.9 | -14.85 | -23.0 | -26.96 | -36.55 | -32.62 | -6.26 | 28.26 | 78.52 | 90.41 | 5191.76 | 10266.73 | 10615.13 | 5827.82 | 5818.17 | 707.17 | 311.96 | -29.65 | -44.07 | -48.84 | -163.5 | -172.25 | -223.92 | -261.18 | -199.62 | -219.73 | -51.68 | -65.5 | -102.55 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10615.13 | -261.18 | 757.85 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
-66.16 | $ 1.68 | 1.9 % | $ 94.6 M |  China |
 |
Aptorum Group Limited
APM
|
-20.19 | $ 1.08 | -0.19 % | $ 5.89 M | China |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 65.3 | 0.46 % | $ 8.73 B |  USA |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 210.55 | 0.86 % | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.41 | 2.4 % | $ 8.2 B |  Australia |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Autolus Therapeutics plc
AUTL
|
-51.64 | $ 1.86 | -2.62 % | $ 475 M |  Britain |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | USA |
 |
Biogen
BIIB
|
9.76 | $ 187.47 | 0.79 % | $ 27.3 B | USA |
 |
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
BioVie
BIVI
|
-92.27 | $ 1.29 | -0.77 % | $ 1.91 M | USA |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
1.11 | $ 100.15 | 1.31 % | $ 27.2 B | Germany |
 |
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
21.78 | $ 27.62 | -0.43 % | $ 1.34 B | USA |
 |
BioXcel Therapeutics
BTAI
|
64.02 | $ 1.98 | -1.0 % | $ 5.02 M | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
114.5 | $ 11.85 | 4.45 % | $ 766 M | USA |
 |
BioDelivery Sciences International
BDSI
|
45.18 | - | -4.8 % | $ 255 M | USA |
 |
Axon Enterprise
AXON
|
16.2 | $ 629.67 | 2.72 % | $ 47.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M |  Israel |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.65 | -0.38 % | $ 16.6 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AstraZeneca PLC
AZN
|
20.44 | $ 95.16 | 1.22 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
-1239.35 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.17 | -3.02 % | $ 9.07 B | Israel |
 |
Burford Capital Limited
BUR
|
10.1 | $ 9.34 | 0.59 % | $ 1.52 B | Britain |
 |
Catalyst Biosciences
CBIO
|
540.06 | $ 10.92 | -0.46 % | $ 719 M | USA |
 |
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | USA |